SMARTKEM, INC. APPOINTS MELISA A. DENIS TO THE BOARD OF DIRECTORS

MANCHESTER, England, Nov. 28, 2023 /PRNewswire/ — SmartKem, Inc. (OTCQB: SMTK), a…

WiMi Announced an Optimized Classification Based on EEG and fNIRS

BEIJING, Nov. 28, 2023 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI)…

Akeso Launches Construction of Shanghai Global R&D Center to Accelerate Its Innovation Globalization Strategy

HONG KONG, Nov. 28, 2023 /PRNewswire/ — The groundbreaking ceremony for Akeso (9926.HK) …

Henniges Automotive Officially Names Linda Hellebuyck as Chief Financial Officer

AUBURN HILLS, Mich., Nov. 28, 2023 /PRNewswire/ — Henniges Automotive has officially…

Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award

BOSTON, Nov. 28, 2023 /PRNewswire/ — Dr. Liu Jian, President of the Drug…

Nature Wood Group Limited Provides Update on First-Half 2023 Financial Performance

MACAU, Nov. 28, 2023 /PRNewswire/ — Nature Wood Group Limited ("Nature Wood" or…

Actinogen XanaCIDD Phase 2a trial in patients with depression and cognitive impairment: enrolment accelerating and on track for results in second quarter of 2024

US$3.2 million (A$4.8m) R&D tax incentive rebate received from Australian Tax Office…

Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally

SINGAPORE, Nov. 29, 2023 /PRNewswire/ — Wonder Technologies PTE. LTD ("Wonder Tech"…